CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Operating expenses
Research and development	$ 2,008	$ 398
General and administrative	1,336	1,122
Total operating expenses	3,344	1,520
Net operating loss	(3,344)	(1,520)
Other income (loss)
Interest income	20	8
Total other income	20	8
Net loss	$ (3,324)	$ (1,512)
Net loss per share, basic and diluted (in dollars)	$ (0.90)	$ (0.89)
Basic and diluted weighted average number of common shares outstanding	3,692	1,700